{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:32:04Z","timestamp":1791131524250,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,3,11]],"date-time":"2006-03-11T00:00:00Z","timestamp":1142035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00125-006-0190-y","type":"journal-article","created":{"date-parts":[[2006,3,10]],"date-time":"2006-03-10T12:14:06Z","timestamp":1141992846000},"page":"921-929","source":"Crossref","is-referenced-by-count":129,"title":["Chemokines as risk factors for type 2 diabetes: results from the MONICA\/KORA Augsburg study, 1984\u20132002"],"prefix":"10.1007","volume":"49","author":[{"given":"C.","family":"Herder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Thorand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Meisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Illig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,11]]},"reference":[{"key":"190_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","volume":"27","author":"JC Pickup","year":"2004","unstructured":"Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813\u2013823","journal-title":"Diabetes Care"},{"key":"190_CR2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-005-1764-9","volume":"48","author":"H Kolb","year":"2005","unstructured":"Kolb H, Mandrup-Poulsen T (2005) An immune origin of type 2 diabetes? Diabetologia 48:1038\u20131050","journal-title":"Diabetologia"},{"key":"190_CR3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327\u2013334","journal-title":"JAMA"},{"key":"190_CR4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","volume":"51","author":"A Festa","year":"2002","unstructured":"Festa A, D\u2019Agostino R, Tracey RP, Haffner SM (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51:1131\u20131137","journal-title":"Diabetes"},{"key":"190_CR5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00125-002-0829-2","volume":"45","author":"S M\u00fcller","year":"2002","unstructured":"M\u00fcller S, Martin S, Koenig W et al (2002) Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45:805\u2013812","journal-title":"Diabetologia"},{"key":"190_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archinte.163.1.93","volume":"163","author":"B Thorand","year":"2003","unstructured":"Thorand B, L\u00f6wel H, Schneider A et al (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984\u20131998. Arch Intern Med 163:93\u201399","journal-title":"Arch Intern Med"},{"key":"190_CR7","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","volume":"291","author":"JB Meigs","year":"2004","unstructured":"Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978\u20131986","journal-title":"JAMA"},{"key":"190_CR8","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2337\/diabetes.51.4.1088","volume":"51","author":"E Exel van","year":"2002","unstructured":"van Exel E, Gussekloo J, de Craen AJ, Fr\u00f6lich M, Bootsma-Van Der Wiel A, Westendorp RG (2002) Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 51:1088\u20131092","journal-title":"Diabetes"},{"key":"190_CR9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","volume":"2","author":"C Gerard","year":"2001","unstructured":"Gerard C, Rollins BJ (2001) Chemokines and disease. Nat Immunol 2:108\u2013115","journal-title":"Nat Immunol"},{"key":"190_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0303-7207(01)00394-X","volume":"175","author":"CC Gerhardt","year":"2001","unstructured":"Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD (2001) Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 175:81\u201392","journal-title":"Mol Cell Endocrinol"},{"key":"190_CR11","first-page":"1267","volume":"86","author":"JM Bruun","year":"2001","unstructured":"Bruun JM, Pedersen SB, Richelsen B (2001) Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 86:1267\u20131273","journal-title":"J Clin Endocrinol Metab"},{"key":"190_CR12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","volume":"95","author":"IF Charo","year":"2004","unstructured":"Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95:858\u2013866","journal-title":"Circ Res"},{"key":"190_CR13","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","volume":"112","author":"KE Wellen","year":"2003","unstructured":"Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785\u20131788","journal-title":"J Clin Invest"},{"key":"190_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s001250051124","volume":"42","author":"D Zozulinska","year":"1999","unstructured":"Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B (1999) Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42:117\u2013118","journal-title":"Diabetologia"},{"key":"190_CR15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2249.2000.01324.x","volume":"121","author":"S Nomura","year":"2000","unstructured":"Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S (2000) Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121:437\u2013443","journal-title":"Clin Exp Immunol"},{"key":"190_CR16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/diacare.26.5.1647","volume":"26","author":"K Esposito","year":"2003","unstructured":"Esposito K, Nappo F, Giugliano F et al (2003) Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care 26:1647","journal-title":"Diabetes Care"},{"key":"190_CR17","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.2337\/diacare.26.10.2883","volume":"26","author":"L Piemonti","year":"2003","unstructured":"Piemonti L, Calori G, Mercalli A et al (2003) Fasting plasma leptin, tumor necrosis factor-\u03b1 receptor 2, and monocyte chemoattracting protein-1 concentration in a population of glucose-tolerant and glucose-intolerant women. Diabetes Care 26:2883\u20132889","journal-title":"Diabetes Care"},{"key":"190_CR18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.0000049742.68848.99","volume":"107","author":"JA Lemos de","year":"2003","unstructured":"de Lemos JA, Morrow DA, Sabatine MS et al (2003) Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107:690\u2013695","journal-title":"Circulation"},{"key":"190_CR19","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2004.07.047","volume":"44","author":"R Deo","year":"2004","unstructured":"Deo R, Khera A, McGuire DK et al (2004) Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44:1812\u20131818","journal-title":"J Am Coll Cardiol"},{"key":"190_CR20","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s00125-004-1494-4","volume":"47","author":"E Simeoni","year":"2004","unstructured":"Simeoni E, Hoffmann MM, Winkelmann BR et al (2004) Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia 47:1574\u20131580","journal-title":"Diabetologia"},{"key":"190_CR21","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2307\/2533444","volume":"50","author":"WE Barlow","year":"1994","unstructured":"Barlow WE (1994) Robust variance estimation for the case-cohort design. Biometrics 50:1064\u20131072","journal-title":"Biometrics"},{"key":"190_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0895-4356(88)90084-4","volume":"34","author":"WHO MONICA Project Principal Investigators (prepared by H. Tunstall-Pedoe)","year":"1988","unstructured":"WHO MONICA Project Principal Investigators (prepared by H. Tunstall-Pedoe) (1988) The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 34:105\u2013114","journal-title":"J Clin Epidemiol"},{"key":"190_CR23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000177906","volume":"40","author":"V Schaeffler","year":"1996","unstructured":"Schaeffler V, D\u00f6ring A, Winkler G, Keil U (1996) Trends in food consumption in a south German population from 1984\/85 to 1989\/90: results from the WHO MONICA project Augsburg. Ann Nutr Metab 40:129\u2013136","journal-title":"Ann Nutr Metab"},{"key":"190_CR24","first-page":"318","volume":"1","author":"HW Hense","year":"1998","unstructured":"Hense HW, Filipiak B, D\u00f6ring A, Stieber J, Liese A, Keil U (1998) Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany. Results from the 1984\/85, 1989\/90 and 1994\/1995 surveys. CVD Prev 1:318\u2013327","journal-title":"CVD Prev"},{"key":"190_CR25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archinte.162.1.82","volume":"162","author":"C Meisinger","year":"2002","unstructured":"Meisinger C, Thorand B, Schneider A, Stieber J, D\u00f6ring A, L\u00f6wel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus\u2014The MONICA Augsburg cohort study. Arch Intern Med 162:82\u201389","journal-title":"Arch Intern Med"},{"key":"190_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CDLI.10.1.133-139.2003","volume":"10","author":"W Jager de","year":"2003","unstructured":"de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10:133\u2013139","journal-title":"Clin Diagn Lab Immunol"},{"key":"190_CR27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/clinchem\/46.7.934","volume":"46","author":"WL Hutchinson","year":"2000","unstructured":"Hutchinson WL, Koenig W, Fr\u00f6hlich M, Sund M, Lowe GD, Pepys MB (2000) Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 46:934\u2013938","journal-title":"Clin Chem"},{"key":"190_CR28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1373\/49.10.1691","volume":"49","author":"N Khuseyinova","year":"2003","unstructured":"Khuseyinova N, Imhof A, Trischler G et al (2003) Determination of C-reactive protein: comparison of three high-sensitivity immunoassays. Clin Chem 49:1691\u20131695","journal-title":"Clin Chem"},{"key":"190_CR29","first-page":"3215","volume-title":"SAS\/STAT user\u2019s guide, version 8","author":"SAS Institute Inc","year":"1999","unstructured":"SAS Institute Inc (1999) SAS\/STAT user\u2019s guide, version 8. SAS, Cary, North Carolina, pp 3215\u20133271"},{"key":"190_CR30","first-page":"4183","volume-title":"SAS\/STAT user\u2019s guide, version 9.1","author":"SAS Institute Inc","year":"2004","unstructured":"SAS Institute Inc (2004) SAS\/STAT user\u2019s guide, version 9.1. SAS, Cary North Carolina, pp 4183\u20134239"},{"key":"190_CR31","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.2337\/diabetes.54.10.2932","volume":"54","author":"B Thorand","year":"2005","unstructured":"Thorand B, Kolb H, Baumert J et al (2005) Elevated levels of interleukin-18 predict the development of type 2 diabetes\u2014Results from the MONICA\/KORA Augsburg Study, 1984\u20132002. Diabetes 54:2932\u20132938","journal-title":"Diabetes"},{"key":"190_CR32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/eje.1.02090","volume":"154","author":"C Herder","year":"2006","unstructured":"Herder C, M\u00fcller-Scholze S, Rating P et al (2006) Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Eur J Endocrinol 154:311\u2013317","journal-title":"Eur J Endocrinol"},{"key":"190_CR33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","volume":"52","author":"J Spranger","year":"2003","unstructured":"Spranger J, Kroke A, M\u00f6hlig M et al (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812\u2013817","journal-title":"Diabetes"},{"issue":"Suppl. 2","key":"190_CR34","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/diabetes.54.suppl_2.S11","volume":"54","author":"C Herder","year":"2005","unstructured":"Herder C, Haastert B, M\u00fcller-Scholze S et al (2005) Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54 (Suppl. 2):S11\u2013S17","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-006-0190-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-006-0190-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T03:52:01Z","timestamp":1586749921000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-006-0190-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1007\/s00125-006-0190-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,11]]}}}